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Background: Early endosomal autoantigen 1 (EEA1) is a membrane tethering factor required for the fusion and
maturation of early endosomes in endocytosis. How the activity of EEA1 is regulated in cells is unclear.
Results: Here we show that endogenous EEA1 is prone to monoubiquitination at multiple sites, owing to an
intrinsic affinity to ubiquitin conjugating enzymes (E2). The E2 interactions enable a ubiquitin ligase (E3)
independent mechanism that decorate EEA1 with multiple mono-ubiquitin moieties. Expression of an ubiquitin-
EEA1 chimera that mimics native mono-ubiquitinated EEA1 generates giant endosomes abutting the nucleus.
Several lines of evidence suggest that this phenotype is due to increased endosome fusion and a simultaneous
blockade on an endosome recycling pathway. The latter is likely caused by diminished endosome fission in cells
expressing ubiquitin-EEA1.
Conclusion: Our results demonstrate that ubiquitination may dramatically affect the activity of an endosome fusion
factor to alter endosome morphology and trafficking pattern, and thereby implicating an unexpected role of
ubiquitin signaling in endocytosis.
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trients from the environment. This process is at least in
part dependent on endocytosis, a cellular pathway in
which a portion of the plasma membranes invaginate,
forming vesicular structures termed endosomes. Endo-
cytosis also imparts regulatory functions in a large number
of processes ranging from cellular signaling transduction
to protein quality control [1,2]. Upon entering the cytosol,
the early endosomes undergo a complex maturation
process as they traverse towards a perinuclear region via
the cellular cytoskeletal system. Meanwhile, through ac-
quisition of new proteins and lipids as well as by fusing
with other endosome vesicles, early endosomes mature
into late endosomes, which eventually fuse with the lyso-
somes to turn over internalized molecules [3]. It is also
known that early endosomes constantly undergo a fission
process [4]. Some fission products form recycling
endosomes, which help to bring certain internalized* Correspondence: yihongy@mail.nih.gov
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distribution, and reproduction in any mediummembrane receptors back to the plasma membrane for
re-usage [5,6]. In addition to receiving materials from the
plasma membranes, the endosomes can also exchange
contents with the Golgi apparatus through vesicular traf-
ficking. Thus, the endocytic membrane system is highly
dynamic and interactive, a feature required to maintain
membrane equilibrium and structural integrity of many
intracellular organelles.
Early endosomal autoantigen 1 (EEA1) is an essential
component of the endosomal fusion machinery [7,8]. It
contains a C-terminal FYVE domain responsible for bind-
ing phosphatidyl inositol-3-phosphate on the membrane,
two binding sites that impart communications with the
master endocytosis regulator Rab5, and a long helical do-
main required for oligomerization of EEA1 [7,9-13]. These
features confer membrane binding and fusion-inducing
activities to EEA1 because once the membrane-associated
EEA1 oligomerizes, it tethers endosomes and primes them
for subsequent fusion [14].
We previously identified EEA1 as a potential substrate
for the ubiquitin selective segregase p97 [15], an ATPase
that operates in many cellular processes to separate
ubiquitinated polypeptides from membranes, DNA, orntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 EEA1 undergoes mono-ubiquitination in cells. A, Cell
extracts prepared from HEK293 cells transfected with HA-tagged
ubiquitin- (HA-Ub) and EEA1-FLAG-expressing plasmids (+) or a
control empty vector (−) were subject to immunoprecipitation with
FLAG antibodies. The precipitated materials were analyzed by
immunoblotting (IB) with the indicated antibodies. The bracket
indicates ubiquitinated EEA1 species. B, As in A, except that cells
expressing HA-Ub were used and that immunoprecipitation was
performed with anti-EEA1 antibodies. C, As in B, except that cells
expressing the indicated Ub variants were used.
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that p97 may regulate endosome fusion by controlling
the oligomerization status and therefore the tethering
activity of EEA1. In this study, we further demonstrate
that similar to other p97 substrates, EEA1 is subject to
regulation in cells by ubiquitination, which appears to
control not only the size of the endosomes, but also
their trafficking pattern.
Results
Monoubiquitination of EEA1 in cells
To investigate whether EEA1 is ubiquitinated in cells, we
expressed full-length FLAG-tagged wild type EEA1 to-
gether with hemagglutinin (HA)-tagged ubiquitin in
HEK293 cells. EEA1-FLAG appeared functional as a frac-
tion of it was localized to the endosomes [15]. Cell extracts
were subject to immunoprecipitation with the FLAG anti-
body. Immunoblotting showed that when EEA1-FLAG
was expressed, the EEA1 antibody stained not only the ec-
topically expressed EEA1, but also a few EEA1-containing
bands migrating more slowly. These additional EEA1-
containing species corresponded to ubiquitinated EEA1
because they were also recognized by anti-HA antibodies,
as demonstrated by two-color immunoblotting (Figure 1A).
As expected, no ubiquitinated EEA1 could be detected
when FLAG-EEA1 plasmid was omitted during trans-
fection. Ubiquitinated EEA1 was also detected with en-
dogenous EEA1 using a similar method (Figure 1B).
The migration pattern of ubiquitinated EEA1 remained
similar when a ubiquitin mutant lacking lysine residues
was expressed (Figure 1C). Since this lysine-less ubiqui-
tin mutant did not support the formation of ubiquitin
chain, our results suggest that a fraction of EEA1 is
ubiquitinated in cells at several sites, each with a single
ubiquitin moiety.
EEA1 has an intrinsic affinity to ubiquitin conjugating
enzymes
Protein ubiquitination usually requires three types of
enzymes, an E1 activating enzyme, an E2 conjugating
enzyme and an E3 ligase [18]. A conjugation reaction
also depends on ubiquitin and ATP. In most cases, these
enzymes would form polymerized chains on substrates
and the type of ubiquitin chains can dictate the func-
tional consequence of a ubiquitination reaction [19].
To dissect the mechanism by which EEA1 preferentially
undergoes monoubiquitination, we developed an in vitro
ubiquitination assay using post-nuclear extract. To this
end, cells expressing EEA1-FLAG were treated with a low
salt buffer to disrupt the plasma membrane. We reasoned
that the enzymes involved in EEA1 ubiquitination likely
reside in either cytosol or on the endosome membranes.
We therefore obtained a post-nuclear extract fraction
containing both endosomes and cytosol and incubated it
Ramanathan et al. Cell & Bioscience 2013, 3:24 Page 3 of 11
http://www.cellandbioscience.com/content/3/1/24with HA-tagged ubiquitin and an ATP regenerating
system. Immunoblotting showed that EEA1 was rapidly
ubiquitinated in the presence of ATP and ubiquitin
(Figure 2A). In the absence of exogenously added ATP,
only a small amount of ubiquitinated EEA1 was generated,
likely due to the residual endogenous ATP, which was
present at millimolar concentrations in cells. By contrast,
no ubiquitinated EEA1 was detected in the absence ofFigure 2 EEA1 can interact with E2 to undergo E3-independent mono
nuclear extract isolated from cells expressing EEA1-FLAG in the presence o
analyzed by dual color immunoblotting with the indicated antibodies. B, A
the arrow). The bracket indicates 3XFLAG peptide. C, Purified EEA1 was inc
with E1, HA-Ub, and ATP. Where indicated, EEA1-FLAG was omitted as neg
the HA (top panel) and EEA1 antibodies (bottom panel). D, As in A, except
EEA1 with Ube2A. E, Purified Ube2A was injected into a CM5 chip immobil
of Ube2A with EEA1 was monitored by Surface Plasmon Resonance. F, The
E2 concentrations.ubiquitin. This was not surprising given that endogenous
ubiquitin was significantly diluted during cell lysis.
We next wished to reconstitute ubiquitination of EEA1
using purified proteins. We incubated purified EEA1
(Figure 2B), ubiquitin activating enzyme (E1), ubiquitin,
and ATP together with a panel of E2 conjugating enzymes.
After incubation, immunoblotting showed that several
E2 enzymes were able to support EEA1 ubiquitination even-ubiquitination. A, In vitro ubiquitination was performed with a post-
f HA-tagged ubiquitin and ATP as indicated. The reactions were
Coomassie-blue stained gel showing the purified EEA1 (indicated by
ubated with the indicated E2 ubiquitin conjugating enzymes together
ative controls. The reactions were analyzed by immunoblotting with
that the indicated ubiquitin variants were used. E, F, Interaction of
ized with EEA1-FLAG at the indicated concentrations. The interaction
interaction of EEA1-FLAG with Ube2A was plotted against the
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Ube2A(HR6a), Ube2H(UbcH2), Ube2D1(UbcH5a) and
Ube2E1(UbcH6). Ube2A appeared to be the most efficient
one in mediating EEA1 ubiquitination (Figure 2C).
As mentioned above, ubiquitination often involves an
E3 ligase that serves as a matchmaker to bring a sub-
strate in proximity to a ubiquitin-charged E2 enzyme
[20]. One method that allows bypass of an E3 ligase in
ubiquitination is to utilize a ubiquitin recognition motif
(UIM) in a substrate, which binds directly to the ubiqui-
tin moiety on an activated E2 [21,22]. This mechanism
requires a hydrophobic surface composed of Ile44 and
Leu8 in ubiquitin, which serves as the docking site for
UIM. EEA1 does not contain any identifiable UIMs, but
it might have a cryptic ubiquitin binding site that medi-
ates its own ubiquitination. To exclude this possibility,
we performed in vitro EEA1 ubiquitination using ubiqui-
tin mutants defective in UIM binding [23]. The result
showed that these ubiquitin mutants were as effective as
wild type ubiquitin in ubiquitination of EEA1 (Figure 2D).
This observation raised the possibility that EEA1 may
directly communicate with an E2 enzyme(s) to receive
ubiquitin from it. This conclusion was indeed con-
firmed by Surface Plasmon Resonance (SPR) experi-
ments using purified EEA1 and an E2. These in vitro
binding experiments demonstrated that EEA1 had an
intrinsic affinity to Ube2A with Kd of ~9.7 ± 0.54 μM
(Figure 2E, F). By contrast, Ube2G2 bound EEA1 with a
significantly reduced affinity (data not shown), consist-
ent with the fact that Ube2G2 could not ubiquitinate
EEA1 in vitro.
Expression of a ubiquitin-EEA1 chimera generates giant
vacuole-like endosomes
To understand the functional consequence of EEA1
monoubiquitination, we took advantage of the observation
that in-frame fusion of ubiquitin to a protein often mimics
endogenously generated mono-ubiquitinated protein
[24,25]. We substituted the C-terminal glycine in ubiquitin
to valine to avoid cleavage of ubiquitin by cellular
deubiquitinases and then fused the coding sequence of
UbG76V to the 5′-end of the EEA1 gene. This construct
allowed the expression of a constitutively 'ubiquitinated'
EEA1 variant (Ub-EEA1), carrying just a single ubiquitin
moiety at the N-terminus. We expressed EEA1 or Ub-
EEA1 in COS7 cells and stained the cells with an EEA1
antibody to visualize the endosomes. In untransfected
cells, the EEA1 antibody stains clusters of small vesicles
in a perinuclear region. Since EEA1 normally func-
tions as a tether that ‘primes’ endosomes for fusion,
overexpression of wild type EEA1 induced endosome clus-
tering and fusion, resulting in enlarged endosome vesicles
(Figure 3A). Intriguingly, approximately 60% of cells ex-
pressing Ub-EEA1 contained giant vacuole-like EEA1-positive membrane structures in proximity to the nucleus
(Figures 3A, B). Co-expressing the early endosome marker
Rab5-GFP showed that Ub-EEA1 and Rab5 were co-
localized in this structure (Additional file 1: Figure S1),
confirming that this structure originated from early endo-
some vesicles, likely due to uncontrolled fusion of early
endosomes. Under electron microscopy, Ub-EEA1-
expressing cells often contained large vacuole-like struc-
tures resembling late endosome/lysosome (Figure 3C).
Since immunoblotting showed that Ub-EEA1 was ex-
pressed at a much lower level than EEA1 (Figure 3D), Ub-
EEA1 appeared much more active than unmodified EEA1
in inducing endosome fusion, causing enlarged and seem-
ingly over-matured endosomes.
To see if the enlarged endosome phenotype depends
on the interplays between Ub-EEA1 and an unknown
ubiquitin receptor in cells, we substituted Ile44 in Ub-
EEA1 with alanine. This isoleucine residue is required
for ubiquitin recognition by all forms of ubiquitin bind-
ing domains in cells. Thus, if an ubiquitin binding ef-
fector is required for Ub-EEA1 to induce enlarged
endosomes, the mutation should abolish the phenotype.
Indeed, even though UbI44A-EEA1 was expressed at a
higher level than Ub-EEA1, as demonstrated by im-
munoblotting (Figure 3D), cells expressing this mutant
only displayed a small increase in size of endosomes,
comparable to cells expressing EEA1 (Figure 3A). Similar
observations were made using a set of EEA1 constructs
that carried a FLAG tag in addition to the ubiquitin fusion
in COS7 cells and in another mammalian cell line, the
HEK293 cells (Additional file 1: Figure S2).
We further characterized the giant endosome struc-
tures generated by Ub-EEA1 using antibodies that label
a variety of subcellular organelles. The results showed
that the Ub-EEA1 positive endosomes did not co-
localize with the Golgi marker β-COP. Interestingly, the
morphology of the Golgi in cells expressing Ub-EEA1
was dramatically altered compared to control cells. In-
stead of forming a stack in a perinuclear region, β-COP
positive Golgi vesicles are completely dispersed throughout
the cell, suggesting a connection between the endocytic
pathway and Golgi morphology (Figure 4A-C). By contrast,
the ER and mitochondrial morphology were largely un-
affected, and Ub-EEA1 did not colocalize with either ER or
mitochondrial markers (Figure 4D-I). Intriguingly, immu-
nostaining with a LAMP1 antibody that labels lysosomes
showed that many lysosome vesicles were docked on the
large endocytic structures formed upon Ub-EEA1 expres-
sion (Figure 4J-L). These results suggest that Ub-EEA1
disrupts endocytic homeostasis at least in part by indu-
cing uncontrolled fusion of endosomes that can fuse
further with the lysosomes. The results also suggest that
endocytic membrane homeostasis is critical for
maintaining normal Golgi stack in cells.
Figure 3 Ub-EEA1 expression induced vacuole-like endocytic structures. A, COS7 cells transfected with the indicated plasmids were
immunostained with anti-EEA1 antibodies in red. Cells were counter-stained with DAPI to reveal the nuclei. B, Quantification of Ub-EEA1-induced
giant vacuole phenotype. The percentage of cells with enlarged vacuole-like endosomes in either EEA1 or Ub-EEA1 expressing cells is indicated.
Error bars, SD (n = 3). C, EEA1- or Ub-EEA1-expressing cells were fixed and analyzed by transmission electron microscopy. The arrow indicates a
representative vacuole-like structure in Ub-EEA1-expressing cells. D, Extracts prepared from cells transfected with the indicated plasmids were
analyzed by immunoblotting to determine the expression levels of the indicated proteins.
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transferrin
It was known from previous studies that constitutive ac-
tivation of Rab5 induces uncontrolled fusion of early
endosomes, resulting in giant endosomes [26]. However,
endosomes generated by Rab5 activation (e.g. expression
of the constitutive activated Rab5) are morphologically
distinct from those produced by Ub-EEA1. The former
generates enlarged endosomes that are mostly spherical
whereas as the endosome sheets formed by Ub-EEA1
are often irregular in shapes. In addition, the endosome
structures generated by Ub-EEA1 are also generally larger
than those by Rab5 Q79L expression. These differences
suggest that uncontrolled fusion may not be the only
contributor that forms the abnormal endocytic structures
in Ub-EEA1 expressing cells.
We examined whether Ub-EEA1-expressing cells had
other endocytic trafficking defects. We first analyzed theinternalization of Texas red-labeled transferrin in cells
expressing either EEA1 or Ub-EEA1. Following incuba-
tion of the cells with labeled-transferrin on ice, we re-
moved unbound transferrin by washing and then
incubated the cells at 37°C in a transferrin free medium
for different time points. In EEA1-expressing cells,
transferrin was internalized and accumulated in EEA1
positive endosomes over time (Figure 5). In general, cells
internalizing transferrin gradually lost the transferrin
signal as a result of an endocytic recycling process.
Interestingly, cells expressing Ub-EEA1 failed to take up
transferrin (Figure 5). We questioned whether enlarge-
ment of endosomes in general can block transferrin up-
take. We therefore performed the transferrin uptake
experiment using cells expressing Rab5 Q79L. Despite
the presence of a large number of enlarged endosomes,
these cells effectively internalized Texas red-labeled
transferrin (Additional file 1: Figure S3), consistent with
Figure 4 Expression of Ub-EEA1 alters Golgi morphology and induces fusion of lysosome with endosome. COS7 cells expressing Ub-EEA1
were fixed and immunostained with EEA1 antibody (B, E, H, K) together with antibodies against β-COP (A), PDI (D), Tom20 (G), or Lamp1 (J). Cells
were also stained with DAPI in blue to reveal the nuclei. Merged two-color images are shown in C, F, I, L. Scale bars correspond to 20 μm.
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the phenotypic difference between cells containing acti-
vated Rab5 and those expressing Ub-EEA1.
Ubiquitin-EEA1 traps a cell surface receptor at endosomes
One possible explanation for the enlarged endosome
phenotype associated with Ub-EEA1 is that activation of
EEA1 by ubiquitination may not only induce endosome
fusion, but also block an endosome fission process re-
quired for recycling of certain membrane receptors such
as the transferrin receptor to the plasma membrane. This
could lead to a depletion of transferrin receptor from the
cell surface, resulting in abnormal transferrin uptake. This
model also explains why the endosomes in Ub-EEA1 cells
are even larger than those in Rab5 Q79L expressing cells,
as the endosome enlargement induced by Rab5 activation
may be solely due to increased vesicle fusion.To test this hypothesis, we stained cells with an anti-
body that recognizes the transferrin receptor. In wild
type cells, transferrin receptor was mostly localized in
endosomal vesicles concentrated in a perinuclear re-
gion, but small vesicles localized to peripheral regions
of the cells were also frequently observed. These vesi-
cles represented recycling endosomes, which are re-
sponsible for re-distributing internalized transferrin
receptor to the plasma member. Only a few transferrin
receptor molecules were detected on the plasma mem-
brane, suggesting that it was transiently localized to the
cell surface. In Ub-EEA1 expressing cells, transferrin re-
ceptor was almost entirely trapped in the enlarged
endocytic structures. Almost no transferrin receptor
positive recycling endosome vesicles could be detected
(Figure 6). This observation supports our model that
overactivation of EEA1 via ubiquitin conjugation not
Figure 5 Expression of Ub-EEA1 inhibits transferrin uptake. COS7 cells transfected with EEA1- or Ub-EEA1-expressing plasmids were treated
with Texas red-labeled transferrin on ice. After removal of unbound transferrin, cells were incubated in a transferrin-free medium at 37°C for the
indicated time points. Cells were fixed and stained with anti-EEA1 antibody (green) and DAPI (blue). Note that the highlighted Ub-EEA1
-expressing cells fail to take up transferrin compared to the surrounding untransfected cells.
Figure 6 Expression of Ub-EEA1 blocks the recycling of the transferrin receptor. COS7 cells transfected with the Ub-EEA1-expressing
plasmid were fixed and immunostained with an antibody against transferrin receptor (TfR) (A, red channel in C) and anti-EEA1 antibody
(B, green channel in C). Cells were also stained with DAPI in blue. Arrow heads label two untransfected cells that contain many transferrin
receptor molecules in recycling vesicles. By contrast, the circled Ub-EEA1-expressing cells contain few TfR positive recycling vesicles. The scale
bars correspond to 20 μm.
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some recycling.
Discussion
We showed previously that the p97 ATPase can regulate
the oligomeric state of EEA1 to control endosome
morphology and trafficking kinetics [15]. Given that p97
substrates are often polyubiquitinated [27,28], we inves-
tigate whether EEA1 is ubiquitinated in cells. To our
surprise, we find that EEA1 preferentially undergoes
monoubiquitination in cells. In many p97-mediated bio-
logical processes studied to date, the functional conse-
quence of p97 action is to separate ubiquitinated
substrates from large immobile structures, therefore fa-
cilitating their degradation by the proteasome. This has
been best demonstrated for the degradation of misfolded
proteins of the endoplasmic reticulum (ER) via the ER-
associated degradation (ERAD) pathway [29,30]. Because
EEA1 is mostly modified with single ubiquitin moieties,
a functional interplay between ubiquitinated EEA1 and
p97, if exists, may not be directly involved in p97-
dependent modulation of the EEA1 oligomeric state. In
support of this notion, we find that unlike many p97
substrates, inhibition of p97 does not significantly in-
crease the levels of ubiquitinated EEA1. In addition, p97
co-precipitates with both modified and unmodified
EEA1 with apparently similar affinities (data not shown).
Because the activity of the ubiquitin-EEA1 fusion pro-
tein is dependent on Ile44 of ubiquitin, it is possible
that monoubiquitination of EEA1 may recruit an un-
known ubiquitin receptor, which may in turn interfere
with p97-dependent disassembly of EEA1. Alternatively,
monoubiquitination of EEA1 may compete with a paral-
lel polyubiquitination event essential for disassembly of
an EEA1 oligomer complex by p97.
Protein monoubiquitination can occur on many sub-
strates in cells via a variety of mechanisms. One well-
known method of monoubiquitination is via an E3 inde-
pendent mechanism. In this case, monoubiquitination
occurs when a substrate make direct contact with a ubi-
quitin charged E2 enzyme. The substrate can either dir-
ectly interact with the E2 or use a ubiquitin binding
motif to associate with the ubiquitin molecule at the E2
active site [22]. We show that ubiquitination of EEA1 is
apparently due to an intrinsic affinity between EEA1 and
E2 ubiquitin conjugating enzymes. Our in vitro study
suggests that EEA1 can be ubiquitinated by several E2
enzymes in the absence of any E3 ubiquitin ligases. The
functional interplay between EEA1 and E2 conjugating
enzymes are corroborated by our protein interaction
study, which demonstrate a direct interaction between
EEA1 and Ube2A. Although Ube2A appears to be the
most efficient E2 that ubiquitinates EEA1 in vitro, de-
pletion of Ube2A and Ube2B simultaneously usingsiRNA-mediated gene silencing does not significantly
affect the levels of ubiquitinated EEA1 in cells. It is pos-
sible that other E2 enzymes may substitute Ube2A and
Ube2B in their absence. Alternatively, Ube2A and
Ube2B may not be the major E2 for EEA1 ubiquitination
given its preferred nuclear localization. Further experi-
ments would be required to identify the E2s responsible
for EEA1 ubiquitination in cells. In addition, our current
data cannot exclude that cells may use an E3-dependent
mechanism to mono-ubiquitinate EEA1. Despite these
uncertainties, the intrinsic affinity between EEA1 and E2
enzymes as demonstrate in this study clearly indicates the
likelihood that an EEA1 molecule in cells can just receive
ubiquitin directly from one or more E2s, which are
abundant in cells.
One unexpected observation of this study is that expres-
sion of a Ub-EEA1 fusion protein mimicking ubiquitinated
EEA1 induces giant endocytic structures distinct from
those generated by over-activating Rab5. Constitutively ac-
tivated Rab5 recruits wild type EEA1 to the endosome
membrane, which results in enlarged endosomes that are
sphere-shaped. By contrast, the endosomes generated by
Ub-EEA1 expression are larger in size and more irregular
in appearance. Interestingly, despite being driven by the
same promoter, EEA1 and ubiquitin-EEA1 are expressed
in cells at different levels. Ubiquitin moiety fused to EEA1
seems to impart instability, resulting in a much lower level
of expression. Ub-EEA1 bound to the endosome mem-
brane may be constantly turned over by the lysosomes
that are associated with the abnormal endocytic struc-
tures. Although Ub-EEA1 is expressed at a lower level
than EEA1, the endosomes generated by Ub-EEA1 are
much larger than those formed upon EEA1 expression.
Thus, ubiquitinated EEA1 seems to represent an over-
activated form that drives the fusion and maturation of
those vesicles associated with it. Since the activity of Ub-
EEA1 is dependent on isoleucine 44 in the attached ubi-
quitin, it is reasonable to presume that its activity is
dependent on a cellular ubiquitin receptor capable of rec-
ognizing both ubiquitin and EEA1. Regulation of the size
of intracellular vesicles by monoubiquitination of a fusion
factor has not been reported previously. However, a recent
study demonstrated that monoubiquitination of the COPII
component SEC31 can increase the size of COPII-coated
secretory vesicles [31].
The ubiquitinated EEA1 only constitutes a small frac-
tion of the entire pool of EEA1 at the steady state, in
line with other substrates undergoing ubiquitination
[31]. This observation suggest that ubiquitinated EEA1
may act catalytically to induce endosome fusion. More-
over, ubiquitination of endogenous EEA1 may be nor-
mally antagonized in cells by cellular deubiquitinases, a
family of ubiquitin isopeptidases that remove ubiquitin
conjugates from substrate proteins [32]. By limiting
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vesicles to the lysosomes. Several deubiquitinases have
been found to be associated with the endocytic membrane
system including USP8 and AMSH [33-35]. However,
siRNA-mediated depletion of these proteins does not affect
the levels of ubiquitinated EEA1 in cells (data not shown).
Identification of deubiquitinases for EEA1 may further re-
veal the mechanism and biological significance of EEA1
ubiquitination in the context of endocytic trafficking.
Conclusions
In summary, our study establishes EEA1 as a ubiquitin-
regulated factor that may be modified via an E3 inde-
pendent ubiquitin conjugation mechanism in cells. In
addition, ubiquitination may significantly alter EEA1 ac-
tivity to influence endocytosis.
Methods
Cell culture, plasmid preparation, transfection
COS7 and HEK293 cells were purchased from ATCC.
Full length human EEA1 was purchased (OriGene).
EEA1 deletion mutants were made by introducing SgfI
or MluI sites at desired positions using PCR based site-
directed mutagenesis. Restriction digestion using MluI
or SgfI and religation yielded desired deletion mutants.
To make plasmid expressing the EEA1-ubiquitin fusion
protein, the ubiquitin open reading frame was amplified
with primers carrying mutation to generate a ubiquitin
G76V variant. The primers also included EEA1 se-
quences flanking the ubiquitin sequences. The resulting
PCR product was used as primers for subsequent site-
directed insertional mutagenesis using EEA1 or EEA1-
FLAG expressing plasmid as templates to yield in frame
N-terminal Ub G76V fusion to EEA1. Site directed mu-
tagenesis was performed using a kit from Strategen fol-
lowing manufacture’s protocol. TransIT-293 (Mirus) and
FuGENE 6 (Roche) were used for plasmid transfection
in HEK293 and COS7 cells, respectively.
Antibodies, proteins, and chemicals
Rabbit anti-EEA1 (Cell Signaling), rabbit anti-FLAG
(Sigma); mouse anti-EEA1 (BD Biosciences); rabbit anti-
β-COP (Thermo Scientific, IL), rabbit PDI (Enzo life sci-
ences, NY), mouse Tom20 (clone F10, Santa Cruz Bio-
technology, CA) and mouse Lamp1 (clone H5G11, Santa
Cruz Biotechnology, CA) were used. Transferrin-568, goat
anti-mouse or goat anti-rabbit conjugated to Alexa-568
and Alexa-488 were from Invitrogen. Goat anti-mouse
conjugated to infrared dye IR680 and goat anti-rabbit con-
jugated to IR800 were from Rockland (Rockville, MD).
GST-E1 and ubiquitin conjugating enzyme used in this
study were purchased from BostonBiochem. Purification
of Ube2g2 was described previously [36].Purification of EEA1
To purified EEA1, HEK293 cells were transfected with a
plasmid expressing FLAG-tagged full length EEA1. Cells
were harvested 72 hours post transfection in a buffer
containing 1% DeoxyBig CHAP, 30 mM Tris. HCl pH
7.4, 150 mM potassium acetate, 4 mM magnesium acet-
ate and a protease inhibitor cocktail. The cleared cell ex-
tract was incubated with FLAG-agarose beads (Sigma)
and the bound materials were extensively washed with a
buffer containing 0.1% DeoxyBig CHAP, 30 mM Tris.
HCl pH 7.4, 150 mM potassium acetate, 4 mM magne-
sium acetate. The bound materials were eluted using 0.2
mg/ml 3X FLAG peptide (Sigma) in 25 mM Hepes, pH
7.2, 115 mM potassium acetate, 5 mM sodium acetate,
2.5 mM magnesium acetate.
In vitro ubiquitination
To ubiquitinate EEA1 using PNS, HEK293 cells treated
with a hypotonic low salt buffer (50 mM Hepes, 7.3, 10
mM potassium chloride, 2 mM magnesium chloride, 0.5
mM DTT, and a protease inhibitor cocktail) were ho-
mogenized with a Dounce-homogenizer. After centrifu-
gation at 1000 g for 5 min at 4°C, the postnuclear
supernatant (PNS) fraction was collected and used in an
in vitro ubiquitination reaction containing 25 μg HA-
tagged ubiquitin, 1 μg ubiquitin aldehyde, 0.2 μg GST-E1,
an ATP regenerating system, ~1 mg PNS in a 120 μl vol-
ume. After incubation at 37°C, aliquots taken at different
time points were lysed in the NP40 lysis buffer (50 mM
Tris–HCl pH 7.4, 150 mM sodium chloride, 2 mM mag-
nesium chloride, 0.5% NP40, and a protease inhibitor
cocktail). EEA1 immunoprecipitated with FLAG beads
was analyzed by immunoblotting. In vitro ubiquitination
with purified components were performed in 20 μl reac-
tion buffer (25 mM Tris HCl, pH 7.4, 2 mM magnesium/
ATP, and 0.1 mM DTT) containing 40 ng GST-E1, 4 μl
HA-ubiquitin, ~0.5 μg EEA1-FLAG, an ATP regenerating
system, and 1 μl indicated E2 conjugating enzymes. The
reaction was stopped by addition of the Lamili buffer and
analyzed by immunoblotting.
Surface plasmon resonance interaction analysis
Surface plasmon resonance interaction experiments were
carried out at 25°C on a Biacore 2000 system (GE
Healthcare). Purified EEA1-FLAG was covalently at-
tached to a carboxymethyl dextran-coated gold surface
(CM5 Chip; GE Healthcare) using an amide couple kit
following the manufacturer’s suggested protocol. Briefly,
the carboxymethyl group of dextran was activated with
N-ethyl-N’-(3-dimethylaminopropyl) carbodiimide (EDC)
and N-hydroxysuccinimide (NHS). EEA1-FLAG in a
buffer containing 10 mM sodium acetate (pH 4.5) was
injected at a flow rate of 10 μL/min with 2-min contact
time, resulting in the immobilization of EEA1-FLAG at a
Ramanathan et al. Cell & Bioscience 2013, 3:24 Page 10 of 11
http://www.cellandbioscience.com/content/3/1/24level of ~2,000 RU. Any remaining reactive sites in the
flow cell were blocked by ethanolamine. The E2 interac-
tions were monitored at a flow rate of 20 μL/min with the
E2 concentration ranging from 2.5 to 160 μM. Analysts
were prepared in a buffer containing 10 mM Hepes (pH
7.4), 150 mM NaCl, 3 mM EDTA, 0.005% (vol/vol) surfac-
tant P20. Regeneration was achieved by injecting a buffer
containing 2 M NaCl. SPR signal was normalized by using
a reference flow cell containing no EEA1. For each E2
variant, at least 2 measurements were made.Immunostaining, confocal microscopy and electron
microscope analyses
For EEA1 staining, cells plated on coverslips for 24 h
were fixed in 2% formaldehyde in PBS for 10 min, rinsed
in PBS and blocked for 15 min in PBS containing 10%
FBS. Post-blocking, the cells were rinsed and incubated
with mouse or rabbit anti-EEA1 primary antibodies
(1:100 dilution) in PBS containing 10% FBS and 0.2%
saponin. For p97 staining, cells were fixed in 4% parafor-
maldehyde containing 250 mM sucrose, permeabilized
and stained with mouse anti-p97 antibody in PBS
containing 0.1% Igepal CA-630 and detected with sec-
ondary goat anti-mouse or goat anti-rabbit secondary
antibodies conjugated to Alexa fluro-568 or 488. To
track endocytic cargoes, cells were washed and starved
for 30 min in serum-free DMEM containing 0.5% BSA
followed by 15 min incubation with labeled Transferrin
(5 μg/ml) on ice. The cells were washed twice with PBS
and the bound labeled cargoes were allowed to
internalize for different time points by incubating the
cells at 37°C. All images were obtained using a 510 LSM
Confocal microscope (Zeiss) with a 10× Plan Apo ob-
jective and processed using Adobe Photoshop 7.0. For
electron microscope analyses, COS7 cells were treated
with either DMSO or 10 μM EerI for 3 h. Cells were
washed with PBS and then fixed with 2% glutaraldehyde
in 0.1 M cacodylate buffer at room temperature for 1 h
prior to electron microscope analysis.Additional file
Additional file 1: Figure S1. EEA1 is co-localized with Rab5. Figure S2.
Ub-EEA1 expression generates enlarged endosomes. Figure S3. Rab5
Q79L expression enlarges early endosomes, but does not affect
transferrin trafficking. (DOC 6301 kb)
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